Detection of hematogenous tumor cell dissemination predicts tumor relapse in patients undergoing surgical resection of colorectal liver metastases

Annals of Surgery

Volumn 241, Issue 2, 2005, Pages 206-207

  Taylor, Bryce ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER ADJUVANT THERAPY; CANCER RELAPSE; EDITORIAL; HUMAN; LIVER LOBECTOMY; LIVER METASTASIS; MEDICAL DECISION MAKING; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT PLANNING;

COLORECTAL NEOPLASMS; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; NEOPLASM CIRCULATING CELLS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS;

EID: 12744269215     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000151793.80040.5a     Document Type: Editorial

References (4)

1. Koch M, Kienle P, Hinz U, et al. Detection of hematogenous tumor cell dissemination predicts tumor relapse in patients undergoing surgical resection of colorectal liver metastases. Ann Surg. 2005;241:199-205.
2. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309-318.
3. Cristofanilli M, Budd GT, Ellis MJ, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004;351;781-791,
4. Turnbull RB Jr. Current concepts in cancer: cancer of the GI tract: colon, rectum, anus: the no-touch isolation technique of resection. JAMA. 1975; 231:1181-1182.